Obicetrapib-866399-87-3
1 Inquiries
866399-87-3
Pharmaceutical Grade
99%
china
10mg
2026-09-07
peptides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionObicetrapib is under investigation in clinical trial NCT02241772 (A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)).Basic Info
-
Product Name:
Obicetrapib
Other Name:Obicetrapib;TA-8995;DEZ-001;Obicetrapib (free base);866399-87-3;UNII-8O74K609HN;AMG-899;8O74K609HN;866399-87-3 (free base);1-Ethyl (2R,4S)-4-[[[3,5-bis(trifluoromethyl)phenyl]methyl][5-(3-carboxypropoxy)-2-pyrimidinyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylate
CAS No.:866399-87-3
Molecular Formula:C32H31F9N4O5
InChIKeys:NRWORBQAOQVYBJ-GJZUVCINSA-N
Exact Mass:722.21507356
UNII:8O74K609HN
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptides
-
Location:
126 AUTUMN ROAD ,LAKEWOOD NEW JERSEY
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2023
-
Certifications:
certifacate for peptieds
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Sweden
Obicetrapib
10 G Aug 8, 2026 Post an enquiry for this product